RANTES induces nasal mucosal inflammation rich in eosinophils, basophils, and lymphocytes in vivo

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 3 PART I, 1998, Pages 873-879

  Kuna, Piotr ^b   Alam, Rafeul ^b   Ruta, Urszula ^b   Gorski, Pawel ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLERGY; ARTICLE; BASOPHIL; CELL MIGRATION; CHEMOTAXIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; EOSINOPHIL; EPITHELIUM CELL; FEMALE; HUMAN; INFLAMMATORY CELL; MALE; MONONUCLEAR CELL; NOSE MUCOSA; PRIORITY JOURNAL;

ADULT; ALLERGENS; BASOPHILS; CELL MOVEMENT; CHEMOTAXIS, LEUKOCYTE; EOSINOPHILS; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNIZATION; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; NASAL MUCOSA; NEUTROPHILS; PLACEBOS; RANTES; RHINITIS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 0031898899     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.3.9610052     Document Type: Article

References (41)

1. Schall, T. J., and K. B. Bacon. 1994. Chemokines, leukocyte trafficking and inflammation. Curr. Opin. Immunol. 6:865-873.
2. Alam, R. 1997. Chemokines in allergic inflammation. J. Allergy Clin. Immunol. 99:273-277.
3. Kelner, G. S., J. Kennedy, K. B. Bacon, S. Kleyensteuber, D. A. Largaespada, N. A. Jenkins, N. G. Copeland, J. F. Bazan, K. W. Moore, T. J. Schall, and A. Zlotnik. 1994. Lymphotactin: a cytokine that represents a new class of chemokine. Science 266:1395-1398.
4. Bazan, J. F., K. B. Bacon, G. Hardiman, W. Wang, K. Soo, D. Rossi, D. R. Greaves, A. Zlotnik, and T. J. Schall. 1997. A new class of membrane-bound chemokine with a CX3C motif. Nature 385:640-644.
5. Schall, T. J., J. Jongstra, B. J. Dyer, J. Jorgensen, C. Clayberger, M. M. Davis, and A. M. Krensky. 1988. A human T cell-specific molecule is a marker of a new gene family. J. Immunol. 141:1018-1025.
6. Kameyoshi, Y., A. Doorschner, A. I. Mallet, E. Christophers, and J.-M. Schroder. 1992. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med. 176:587-592.
7. Stellato, C., L. A. Beck, G. A. Gorgone, D. Proud, T. J. Schall, S. J. Ono, L. M. Lichtenstein, and S. P. Schleimer. 1995. Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokine and glucocorticoids. J. Immunol. 155:410-418.
8. Kwon, O. J., P. J. Jose, R. A. Robbins, T. J. Schall, T. J. Williams, and P. J. Barnes. 1995. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am. J. Respir. Cell Mol. Biol. 12:488-496.
9. Rathanaswami, P., M. Hachicha, M. Sadick, T. J. Schall, and S. R. McColl. 1993. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and IL-8 genes by inflammatory cytokines. J. Biol. Chem. 268:5834-5839.
10. Devergne, O., A. Marfaing-Koka, T. Schall, M.-B. Leger-Ravet, M. Peuchmaur, M.-C. Crevon, T. Kim, P. Galanaud, and D. Emilie. 1994. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J. Exp. Med. 179:1689-1694.
11. Ying, S., Q. Meng, L. Taborda-Barata, Q. Meng, M. Humbert, and A. B. Kay. 1996. Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein. Ear. J. Immunol. 26:70-76.
12. Lim, K. G., H.-C. Wan, P. T. Bozza, M. B. Resnick, D. T. W. Wong, W. W. Cruikshank, H. Kornfeld, D. M. Center, and P. F. Weller. 1996. Human eosinophils elaborate the lymphocyte chemoattractants IL-16 and RANTES. J. Immunol. 156:2566-2570.
13. Schall, T. J., K. Bacon, K. J. Toy, and D. V. Goeddel. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347:669-671.
14. Alam, R., S. Stafford, P. Forsythe, and J. A. Grant. 1993. RANTES is a chemotactic and activating factor for eosinophils. J. Immunol. 150:3442-3447.
15. Kuna, P., M. Iyer, J. Simone, and A. P. Kaplan. 1995. Studies of the activation of human eosinophils by RANTES. Int. Rev. Allergol. Clin. Immunol. 1:4-11.
16. Ebisawa, M., T. Yamada, C. Bickel, D. Klunk, and R. P. Schleimer. 1994. Eosinophil transendothelial migration induced by cytokines: III. Effect of the chemokine RANTES. J. Immunol. 153:2153-2160.
17. Meurer, R., G. Van Riper, W. Feeney, P. Cunningham, D. Hora, Jr., M. S. Springer, D. Euan MacIntyre, and H. Rosen. 1993. Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein la, or human interleukin 8. J. Exp. Med. 178:1913-1921.
18. Beck, L. A., S. Dalke, K. Leiferman, C. A. Bickel, R. Hamilton, H. Rosen, B. Bochner, and R. Schleimer. 1997. Cutaneous injection of RANTES causes eosinophil recruitment: comparison of nonallergic and allergic human subjects. J. Immunol. 159:2962-2972.
19. Kuna, P., S. R. Reddigari, T. J. Schall, D. Rucinski, M. Y. Viksman, and A. P. Kaplan. 1992. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J. Immunol. 149:636-642.
20. Kimata, H., A. Yoshida, C. Ishioka, M. Fujimoto, I. Lindley, and K. Furusho. 1996. RANTES and macrophage inflammatory protein-1α selectively enhance IgE and IgG4 production. J. Exp. Med. 183:2397-2402.
21. Kuna, P., M. Lazaovich, and A. P. Kaplan. 1996. Chemokines in seasonal allergic rhinitis. J. Allergy Clin. Immunol. 97:104-112.
22. Greiff, L., U. Pipkorn, U. Alkner, and C. G. A. Persson. 1990. The "nasal pool" divide applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions. Clin. Exp. Allergy 86:599-605.
23. Jose, P. J., I. M. Adcock, D. A. Griffiths-Johnson, N. Berkman, T. N. C. Wells, T. J. Williams, and C. A. Power. 1994. Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. Biophys. Biochem. Res. Commun. 205:788-794.
24. Dahinden, C. A., T. Geiser, T. Brunner, V. von Tscharner, D. Caput, P. Ferrera, A. Minty, and M. Baggiolini. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J. Exp. Med. 179:751-756.
25. Uguccioni, M. P., P. Loetscher, U. Forssman, B. Dewald, H. Li, S. H. Lima, Y. Li, B. Kreider, G. Garotta, M. Thelen, and M. Baggiolini. 1996. MCP-4, a novel structural and functional analog of MCP-3 eotaxin. J. Exp. Med. 183:2379-2384.
26. Rot, A., M. Krieger, T. Brunner, S. C. Bischoff, T. J. Schall, and C. A. Dahinden. 1992. RANTES and macrophage inflammatory protein 1α induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 176:1489-1495.
27. Lukacs, N. W., R. M. Streiter, K. Warmington, P. Lincoln, S. W. Chensue, and S. L. Kunkel. 1997. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by CC family chemokine in allergic inflammation. J. Immunol. 158:4398-4404.
28. Stafford, S., H. Li, P. A. Forsythe, M. Ryan, R. Bravo, and R. Alam. 1997. Monocyte chemotactic protein-3 (MCP-3)/fibroblast-induced cytokine (FIC) in eosinophilic inflammation of the airways and the inhibitory effects of an anti-MCP-3/FIC antibody. J. Immunol. 158:4953-4960.
29. Rothenberg, M. E., J. A. MacLean, E. Pearlman, A. D. Luster, and P. Leder. 1997. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. 185:785-790.
30. Ponath, P. D., S. Qin, T. W. Post, J. Wang, L. Wu, N. P. Gerard, W. Newman, C. Gerard and C. R. Mackay. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183:2437-2448.
31. Daugherty, B. L., S. J. Siciliano, J. A. DeMartino, L. Malkowitz, A. Sirotina, and M. S. Springer. 1996. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 183:2349-2354.
32. Douglas, J. A., D. Dhami, C. E. Gurr, M. Bulpitt, J. K. Shute, P. H. Howarth, I. J. Lindley, M. K. Church, and S. T. Holgate. 1994. Influence of IL-8 challenge in the nasal mucosa in atopic and nonatopic subjects. Am. J. Respir. Crit. Care Med. 150:1108-1113.
33. Sim, T. C., L. M. Reece, K. A. Hilsmeier, J. A. Grant, and R. Alam. 1995. Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am. J. Respir. Crit. Care Med. 152:927-933.
34. Durham, S. R., S. Ying, V. A. Varney, M. R. Jacobsen, R. M. Sudderick, I. S. MacKay, and A. B. Kay. 1992. Cytokine mRNA expression for IL-3, -4, and -5 and GM-CSF in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J. Immunol. 148:2390-2394.
35. Collins, P. D., S. Marleau, D. A. Grifiths-Johnson, P. J. Jose, and T. J. Williams. 1995. Cooperation between IL-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182:1169-1174.
36. Alam, R., J. York, M. Boyars, S. Stafford, J. A. Grant, J. Lee, P. Forsythe, T. Sim, and N. Ida. 1996. Increased MCP-1, RANTES, and MIP-1 in bronchoalveolar lavage in allergic asthmatic patients. Am. J. Respir. Crit. Care Med. 153:1398-1404.
37. Teran, L. M., N. Noso, M. Carroll, D. E. Davies, S. Holgate, and J.-M. Schroder. 1996. Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways. J. Immunol. 157:1806-1812.
38. Venge, J., M. Lampinen, L. Hakansson, S. Rak, and P. Venge. 1996. Identification of IL-5 and RANTES as the major eosinophil chemo-attractants in the asthmatic lung. J. Allergy Clin. Immunol. 97:1110-1115.
39. Sur, S., H. Kita, G. J. Gleich, T. C. Chenier, and L. W. Hunt. 1996. Eosinophil recruitment is associated with IL-5, but not with RANTES, twenty-four hours after allergen challenge. J. Allergy Clin. Immunol. 97:1272-1278.
40. Rothenberg, M. E., W. F. Owen, Jr., D. S. Silberstein, J. Woods, R. J. Soberman, K. F. Austen, and R. L. Stevens. 1988. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J. Clin. Invest. 81:1986-1991.
41. Schandene, L., G. F. Del Prete, E. Cogan, P. Stordeur, A. Crusiaux, B. Kennes, S. Romagnani, and M. Goldman. 1996. Recombinant interferon-α selectively inhibits the production of IL-5 by human CD4+ T cells. J. Clin. Invest. 97:309-315.